Diabetes Clinical Trials in Illinois

Showing 521-540 of 608 trials

Screening for Early Evidence of Diabetes

NCT00614783

This is a pivotal study to determine the accuracy of a new device (SCOUT) in screening persons for pre-diabetes or diabetes. SCOUT will be compared to the standard screening test (Fasting Plasma Glucose), using the Oral Glucose Tolerance Test as the reference standard. SCOUT uses a rapid, noninvasive, light-based technology to measure the concentration of chemicals in the skin called advanced glycation endproducts (AGEs). Several studies have demonstrated that AGEs accumulate in skin faster in individuals with poor control of blood sugar. Persons will be eligible for the study if they are 'at risk' for diabetes based on their age and other risk factors as defined by the American Diabetes Association.

Diabetes Mellitus, Type 2

VeraLight, Inc.3,478 participantsStarted May 2007

Huntsville, Alabama, United States • San Diego, California, United States • San Diego, California, United States +12 more locations

COMPLETEDPhase 2121 miles

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione

NCT00743002

This trial is designed to show the effect of treatment with TT223 or placebo on blood glucose control after 12 weeks of treatment with a 6 month follow-up. TT223 is administered by injection once daily to patients currently treated with Metformin and/or Thiazolidinedione.

Diabetes Mellitus, Type 2

OPKO Health, Inc.87 participantsStarted Aug 2008

Artesia, California, United States • Los Angeles, California, United States • Santa Ana, California, United States +17 more locations

Screening for Early Evidence of Diabetes

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione

Diabetes Trials in Other Cities

A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)

Glycemic Control, Safety and Tolerability of TC-6987 Monotherapy in Type 2 Diabetes Mellitus

Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus

The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea)

Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes

Evaluation of Low Source of Signal in SCOUT DS

Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes

Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes

Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus

Impact of a Diabetes Risk Score on Lifestyle Education and Patient Adherence

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 Diabetes

Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Type 2 Diabetes And Chronic Kidney Disease

Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function

Study of Metamucil on Blood Glucose and HbA1c in Type II NIDDM Subjects

Multicenter Worksite Nutrition Study

Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients

Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study

Other Conditions in Illinois